News

Exploring the Options Market Trends for Palantir Technologies

Exploring the Options Market Trends for Palantir Technologies

Whales Investing in Palantir Technologies

Recently, significant investors have displayed a strong bullish sentiment towards Palantir Technologies.

Trade Activities in Palantir Technologies Options

Analyzing the options activity surrounding Palantir Technologies (NASDAQ: PLTR), we identified a total of 261 trades. Among these trades, 48% reflect bullish sentiment, indicating optimism among investors, while 36% lean bearish, showcasing a mix of strategies.

Breaking down the figures, out of the total trades, 31 were put options with a combined value of approximately $1,573,793, whereas calls predominated with a total of 230 trades worth about $27,259,591.

Predicted Price Range for the Stock

The analysis suggests that investors are eyeing a price range for Palantir Technologies between $80.00 and $380.00 over the last three months based on current trading activities. This wide-ranging forecast reflects varying investor strategies and expectations for the stock's movement in the upcoming months.

Volume and Open Interest Insights

Currently, the average open interest for Palantir Technologies options trading stands at 6,921.55 with total trading volume reaching 2,950,217.00. This level of activity indicates a vibrant market for its options, which can be indicative of investor confidence.

30-Day Options Volume and Interest Overview

Within a 30-day framework, the tracking of Palantir Technologies' option volume and open interest reveals significant market movements and investor interest.

Noteworthy Options Trades

The activity of various trades within Palantir Technologies' options market has uncovered several significant transactions:

  • Trade Type: CALL
  • General Sentiment: BULLISH
  • Strike Price: $202.50, Expiration Date: 10/31/25
  • Volume: 19.0K

Similar trades include another CALL option set at $210.00 expiring on 11/21/25, indicating further bullish sentiment from investors.

About Palantir Technologies

Palantir is an innovative analytics software firm focused on harnessing data to enhance efficiencies within its clients' operations. The company offers robust solutions through its Foundry and Gotham platforms, catering to both private and government sectors. Since its inception in 2003 and subsequent IPO in 2020, Palantir has been selective in its partnerships, ensuring alignment with Western values.

Current Position of Palantir Technologies

  • PLTR is currently trading at $196.6, reflecting a 3.69% increase on a trading volume of 28,853,796.
  • Recent RSI indicators suggest the stock might be approaching overbought conditions.
  • The next earnings release is anticipated shortly, adding an extra layer of intrigue to market activity.

Expert Insights on Palantir Technologies

In the last month, analysts have provided updates on PLTR, with two significant ratings emerging. The average target price established is around $195.5. One analyst maintains an Overweight rating, projecting a price of $201, while another has issued a Neutral rating with a target of $190.

Despite the inherent risks associated with trading options compared to stocks, the potential for high returns compels many investors to engage actively. Traders often balance these risks through ongoing education, strategic entry and exit from trades, and careful monitoring of market signals.

Frequently Asked Questions

What is the recent trading activity for Palantir Technologies?

Palantir Technologies has seen significant trading, with 261 option trades, 48% bullish and 36% bearish.

What is the predicted price range for Palantir?

Investors project a price range between $80.0 and $380.0 for Palantir Technologies based on recent trading activity.

What is the average open interest for Palantir's options?

The average open interest for Palantir Technologies options is currently 6,921.55.

What are analysts saying about Palantir Technologies?

Two analysts recently gave ratings, with an average target price of $195.5. One has an Overweight rating at $201.

Why do traders use options?

Options allow for potentially higher returns but come with increased risk. Traders engage in education and strategy to mitigate these risks.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Explosive Growth: Wellness Economy Now A $7.5T Force

Updated Category News Views 56

A Surge in Global Wellness How about this for a shakeup? The global wellness economy isn't just surviving; it's roaring. Clocking in at a staggering $7.5 trillion in 2025, it's set on a straight trajectory to $10.9 trillion by 2030. Talk about making waves! This isn't just some passing fad; it's where money's being funneled fast, and for good reason. Why the Boom? Ever...

Continue Reading
Fed Signals Rate Hike as Trading Volumes Surge

Updated Category News Views 45

Trading Volumes Surge Amid Economic Shifts You'd think October had a few tricks up its sleeve with how it pulled traders into the game. The 10-year Treasury yield moved up to 5.01%, making folks wonder just how long we'll keep dancing around inflation debates. With the S&P 500 dipping nearly 1% and the Nasdaq Composite spiraling down over 1.5%, investors weren't exactly...

Continue Reading
Navigating Car Wreck Chaos for Legal Protection

Updated Category News Views 46

Clarity Amid Chaos: Handling a Crash in Abilene Let me tell you, if your day starts with a car wreck, every second post-crash counts more than you think. Attorney Chaile Allen out of Abilene's laying down the law on how to protect yourself—because that wreck scene ain't just about bent fenders and bruised egos. It's about getting your ducks in a row for any potential...

Continue Reading
2026 Prix Galien Nominations Spotlight Global Healing

Updated Category News Views 62

Beyond the Hype: Innovating for Healthier Tomorrows Kicking off in Stockholm on December 1st, the 2026 Prix Galien Bridges Awards isn't just some schmooze-fest; it's a hard-hitting showcase of where true innovation can propel healthcare. Over at the Karolinska Institutet, the Galien Foundation is drawing powerhouses from across the Nordics+ region and showcasing...

Continue Reading
CVRx Faces Legal Storm: Class Action Threat Looms

Updated Category News Views 37

Cracks in the Foundation: CVRx's Turmoil Let me tell you, it's not every day you see a company drop a bombshell on investors like CVRx did, shaking up the ole portfolio right down to its socks. NASDAQ:CVRX has found itself embroiled in a class action lawsuit courtesy of a knotty mix of legal woes, unplanned revenue slashes, and executive shake-ups. A few short years ago,...

Continue Reading
Baijiu Shines at Melbourne Cup: A Cultural Exchange

Updated Category News Views 20

Baijiu Brews Cultural Ties at Melbourne Cup If you thought the Melbourne Cup was only about horse racing, think again. This year, the carnival wasn’t just a playground for the equestrian elite but also a stage for cultural exchange, and Chinese baijiu had its moment to shine. It’s not just about sipping a strong spirit; it's about bridging cultures and building...

Continue Reading
MoreBetter's Therapy Co-Investment: A Big Bet on Patient Data

Updated Category News Views 62

Diving Into Uncharted Waters with Bold Moves MoreBetter is stepping right into the murky, unpredictable world of longevity, peptide, and psychedelic therapies with a fresh initiative—the RWE Co-Investment Program. This isn't your run-of-the-mill study announcement; it's a gutsy leap into largely unexplored areas of patient-reported outcomes and real-world evidence. A...

Continue Reading
Pre-Sale Prep: Maximize Your Home's Selling Potential

Updated Category News Views 69

Insights for Sellers: The Road to a Smart Sale Alright, here's the deal: you've got a house to sell, and knowing what to fix up beforehand is like playing a high-stakes game of chess. Miss a move, and it could cost you a chunk of change, or worse, a sale. Enter Rosa Stong, the real estate guru from Becker Stong Real Estate Group, dropping knowledge bombs in a HelloNation...

Continue Reading
Curaleaf Secures Key Approvals in Aurora Acquisition Bid

Updated Category News Views 119

Curaleaf Gets a Green Light for Acquisition Talk about maneuvering a minefield, eh? Curaleaf Holdings just stamped out the last of its paperwork in the cutthroat cannabis industry to acquire Aurora Cannabis. We're looking at the final sign-offs from not one, but two major players: Germany and Canada's competition authorities. That's no small feat when you're trying to...

Continue Reading
Ampa One Partners with Wave Neuroscience for PTSD

Updated Category News Views 106

Ampa and Wave Neuroscience Join Forces In a fresh twist on the neurotechnology scene, Ampa's portable TMS system is teaming up with Wave Neuroscience's MeRT to target PTSD. Science and partnership—combined like a decent scotch and a well-done steak, if you ask me. They've got the FDA clearance on their side, and they're bringing it to the clinics without demanding those...

Continue Reading
angout.com/blog/news?page=2">More News Articles